Table 1.
Clinical and biochemical characteristics
| Value † | |
|---|---|
| Variable | NAFLD |
| Number | 84 |
| Sex (male/female) | 53/31 |
| Age (years) | 54 ± 13 |
| Comorbidities (HT/DM/dyslipidemia) | 43/56/71 |
| Body mass index (kg/m2) | 29.0 ± 4.3 |
| Skin thickness overlying the liver (mm) | 21.0 ± 3.8 |
| Aspartate aminotransferase (IU/L) | 43.6 ± 22.4 |
| Alanine aminotransferase (IU/L) | 61.7 ± 41.2 |
| Albumin (g/dL) | 4.2 ± 0.4 |
| Total bilirubin (mg/dL) | 0.9 ± 0.4 |
| Fasting plasma glucose (mg/dL) | 134.0 ± 42.0 |
| Hemoglobin A1c (%) | 6.8 ± 1.3 |
| HDL‐C (mg/dL) | 50.4 ± 14.6 |
| LDL‐C (mg/dL) | 114.5 ± 33.1 |
| Triglyceride (mg/dL) | 159.5 ± 60.9 |
| Platelet count (×104/μL) | 21.1 ± 6.7 |
| Prothrombin time (% of normal) | 99.5 ± 16.8 |
†
Values are expressed as the mean ± SD or numbers of patients.
DM, diabetes mellitus; HDL‐C, high‐density lipoprotein cholesterol; HT, hypertension; LDL‐C, low‐density lipoprotein cholesterol; NAFLD, non‐alcoholic fatty liver disease.